Table 3 Stability estimates for CPM within and between sessions for the overall sample
|  | Clinical cohort | ICC’s for the absolute difference (95% CI) | ICC’s for the percent change (95% CI) | SEM* | MDC* |
|---|---|---|---|---|---|
Within session | CPM trial 1-CPM trial 2 (baseline) | 0.54 (0.34-0.68) | 0.42 (0.16-0.59) | 6.79 | 18.82 |
CPM trial 1-CPM trial 2 (3Â months) | 0.62 (0.43-0.74) | 0.07 (-0.51-0.36) | 5.96 | 16.52 | |
Healthy cohort | |||||
Within session | CPM trial 1-CPM trial 2 (day 1) | 0.66 (0.55-0.75) | 0.60(0.46-0.70) | 6.37 | 17.66 |
CPM trial 1-CPM trial 2 (day 3) | 0.72 (0.62-0.79) | 0.55 (0.39-0.67) | 6.30 | 17.46 | |
CPM trial 1-CPM trial 2 (day 5) | 0.70 (0.60-0.78) | 0.64 (0.51-0.73) | 6.40 | 17.74 | |
Between session | CPM trial 1 (day1)-CPM trial 1 (day3)-CPM trial 1 (day5) | 0.71(0.62-0.77) | 0.61 (0.49-0.70) | 6.75 | 18.71 |
| Â | CPM trial 2 (day1)-CPM trial 2 (day3)-CPM trial 2 (day5) | 0.68 (0.60-0.76) | 0.59 (0.46-0.69) | 5.93 | 16.44 |